Grey Wolf completes £10m funding for immuno-oncology therapies

11th February 2019 Uncategorised 0

Grey Wolf Therapeutics has completed a £10 million series A financing to fund development of immuno-oncology therapies to increase tumour visibility.

More: Grey Wolf completes £10m funding for immuno-oncology therapies
Source: News